The involvement of systemic immunity in mediating antitumor effects was confirmed by (a) induction of tumor-specific CTL response, (b) IFN-γ secretion by splenocytes, and (c) infiltration of CD4+ and CD8+ T cells in tumors that secreted tumor reactive chemokines. This evidence concerns the gene CD4 and neoplasm.